Analysis on the role of CEACAM1 in human mastocytosis
Project/Area Number |
15K08362
|
Research Category |
Grant-in-Aid for Scientific Research (C)
|
Allocation Type | Multi-year Fund |
Section | 一般 |
Research Field |
Human pathology
|
Research Institution | Kyoto University |
Principal Investigator |
|
Project Period (FY) |
2015-04-01 – 2018-03-31
|
Project Status |
Completed (Fiscal Year 2017)
|
Budget Amount *help |
¥4,940,000 (Direct Cost: ¥3,800,000、Indirect Cost: ¥1,140,000)
Fiscal Year 2017: ¥1,560,000 (Direct Cost: ¥1,200,000、Indirect Cost: ¥360,000)
Fiscal Year 2016: ¥1,690,000 (Direct Cost: ¥1,300,000、Indirect Cost: ¥390,000)
Fiscal Year 2015: ¥1,690,000 (Direct Cost: ¥1,300,000、Indirect Cost: ¥390,000)
|
Keywords | マスト細胞 / CEACAM1 / KIT / SHP-1 / 甲状腺髄様癌 / Src family kinases / マストサイトーシス |
Outline of Final Research Achievements |
Carcinoembryonic antigen-related cell adhesion molecule 1 (CEACAM1) is expressed in a number of tumor cell types. The immunoreceptor tyrosine-based inhibitory motif (ITIM)-containing isoforms of this molecule which possess a long cytoplasmic tail (CEACAM1-L) generally play inhibitory roles in cell function by interacting with Src homology 2 domain-containing tyrosine phosphatase (SHP)-1 and/or SHP-2. We found that CEACAM1 was uniquely expressed at high levels in human mastocytosis. This expression was mainly derived from CEACAM1-L isoforms based upon assessment of CEACAM1 mRNA expression. CEACAM1 knockdown upregulated cell growth of HMC1.2 cells harboring KIT mutations detected in clinical mastocytosis. Immunoblotting, ELISA and immunoprecipitaion analysis showed that activated SHP-1 is preferentially associated with CEACAM1 in HMC1.2 cells harboring KIT mutations.
|
Report
(4 results)
Research Products
(21 results)
-
-
-
[Journal Article] RUNX transcription factors potentially control E-selectin expression in the bone marrow vascular niche in mice.2018
Author(s)
Morita K, Tokushige C, Maeda S, Kiyose H, Noura M, Iwai A, Yamada M, Kashiwazaki G, Taniguchi J, Bando T, Hirata M, Kataoka TR, Nakahata T, Adachi S, Sugiyama H, Kamikubo Y.
-
Journal Title
Blood Adv
Volume: 2
Issue: 5
Pages: 509-515
DOI
Related Report
Peer Reviewed / Open Access
-
-
-
-
[Journal Article] Genetic regulation of the RUNX transcription factor family has antitumor effects.2017
Author(s)
Morita K, Suzuki K, Maeda S, Matsuo A, Mitsuda Y, Tokushige C, Kashiwazaki G, Taniguchi J, Maeda R, Noura M, Hirata M, Kataoka T, Yano A, Yamada Y, Kiyose H, Tokumasu M, Matsuo H, Tanaka S, Okuno Y, Muto M, Naka K, Ito K, Kitamura T, Kaneda Y, Liu PP, Bando T, Adachi S, Sugiyama H, Kamikubo Y.
-
Journal Title
J Clin Invest.
Volume: 127(7)
Issue: 7
Pages: 2815-2828
DOI
Related Report
Peer Reviewed / Open Access / Int'l Joint Research
-
[Journal Article] Killer cell immunoglobulin-like receptor 2DL4 is expressed in and suppresses the cell growth of Langerhans cell histiocytosis.2017
Author(s)
Takei Y, Ueshima C, Kataoka TR, Hirata M, Sugimoto A, Rokutan-Kurata M, Moriyoshi K, Ono K, Murakami I, Iwamoto S, Haga H.
-
Journal Title
Oncotarget
Volume: 8
Issue: 23
Pages: 36964-36972
DOI
Related Report
Peer Reviewed / Open Access
-
-
-
-
[Journal Article] Infiltration of PD-1-positive cells in combination with tumor site PD-L1 expression is a positive prognostic factor in cutaneous angiosarcoma.2017
Author(s)
Honda Y, Otsuka A, Ono S, Yamamoto Y, Seidel JA, Morita S, Hirata M, Kataoka TR, Takenouchi T, Fujii K, Kanekura T, Okubo Y, Takahashi K, Yanagi T, Hoshina D, Hata H, Abe R, Fujimura T, Funakoshi T, Yoshino K, Masuzawa M, Amoh Y, Tanaka R, Fujisawa Y, Honda T, Kabashima K.
-
Journal Title
Oncoimmunology.
Volume: 6
Issue: 1
Pages: e1253657-e1253657
DOI
Related Report
Peer Reviewed / Open Access
-
-
-
[Journal Article] Clinical, Morphologic, and Pathologic Features Associated With Increased FDG Uptake in Schwannoma.2016
Author(s)
Miyake KK, Nakamoto Y, Kataoka TR, Ueshima C, Higashi T, Terashima T, Nakatani K, Saga T, Minami S, Togashi K.
-
Journal Title
AJR Am J Roentgenol.
Volume: 207
Pages: 1288-1296
Related Report
Peer Reviewed / Open Access
-
[Journal Article] Loss of Hep Par 1 immunoreactivity in the livers of patients with carbamoyl phosphate synthetase 1 deficiency2016
Author(s)
Yamaguchi M, Kataoka TR, Shibayama T, Fukuda A, Nakazawa A, Minamiguchi S, Sakurai T,Miyagawa-Hayashino A, Yorifuji T, Kasahara M, Uemoto S, Haga H
-
Journal Title
Pathol Int
Volume: 66
Issue: 6
Pages: 333-336
DOI
Related Report
Peer Reviewed / Open Access / Acknowledgement Compliant
-
-
-
[Journal Article] Screening of BCOR-CCNB3 sarcoma using immunohistochemistry for CCNB3: A Clinicopathological Report of Three Pediatric Cases2015
Author(s)
Shibayama T, Okamoto T, Nakashima Y, Kato T, Sakurai T, Minamiguchi S, Kataoka TR, Shibuya S, Yoshizawa A, Toguchida J, and Haga H
-
Journal Title
Pathol Int
Volume: 65
Pages: 410-414
Related Report
Peer Reviewed
-
-